ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

CGTX Cognition Therapeutics Inc

1.96
-0.03 (-1.51%)
최종 업데이트: 23:43:21
15분 지연
기업명 주식 심볼 시장 주식 타입
Cognition Therapeutics Inc CGTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.03 -1.51% 1.96 23:43:21
개장가 저가 고가 종가 전일 종가
1.98 1.9001 2.00 1.99
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
07/05/202420:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/05/202420:39EDGAR2Form 8-K - Current report
12/03/202405:11EDGAR2Form 8-K - Current report
12/03/202405:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/02/202406:44EDGAR2Form 8-K - Current report
21/02/202406:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202409:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202405:07EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
09/01/202406:11EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/01/202406:21EDGAR2Form 8-K - Current report
04/01/202421:30GLOBECognition Therapeutics CEO Issues Letter to Shareholders
30/12/202306:02EDGAR2Form S-3 - Registration statement under Securities Act of..
16/11/202321:30GLOBECognition Therapeutics Releases New Episode of..
15/11/202321:30GLOBECognition Therapeutics Presents Preclinical Data Identifying..
14/11/202307:25EDGAR2Form SC 13D/A - General statement of acquisition of..
13/11/202323:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202321:30GLOBECognition Therapeutics Completes Enrollment in Phase 2 SHINE..
02/11/202320:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202320:41EDGAR2Form 8-K - Current report
02/11/202320:30GLOBECognition Therapeutics Reports Third Quarter 2023 Financial..
27/10/202320:30GLOBECognition Therapeutics and Collaborators at Yale and ACTC..
25/10/202305:30GLOBECognition Therapeutics Presents Complete EEG Findings from..
16/10/202320:30GLOBECognition Therapeutics Presents New Data at CTAD Conference..
12/09/202320:00EDGAR2Form 8-K - Current report
07/09/202320:45GLOBECognition Therapeutics Announces New Conversations Episode..
30/08/202321:00GLOBECognition Therapeutics Announces Participation in Upcoming..
24/08/202320:00EDGAR2Form 8-K - Current report
08/08/202320:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202320:05EDGAR2Form 8-K - Current report
08/08/202320:00GLOBECognition Therapeutics Reports Second Quarter 2023 Financial..
02/08/202320:30GLOBECognition Therapeutics to Report Second Quarter 2023 Results..
11/07/202320:30GLOBECognition Therapeutics Announces Dosing of First Patient in..
05/07/202320:30GLOBECognition Therapeutics and the Alzheimer's Clinical Trials..
28/06/202320:00GLOBECognition Therapeutics Announces Positive Topline Results..
28/06/202308:17GLOBECognition Therapeutics to Host Call and Webcast to Discuss..
20/06/202320:30GLOBECognition Therapeutics Invited to Participate on Panel..
02/06/202320:30GLOBECognition Therapeutics Continues Investor Engagement in June..
23/05/202320:30GLOBECognition Therapeutics Latest Episode of “Conversations”..
18/05/202320:30GLOBECognition Therapeutics Publishes Clinical Evidence that..

최근 히스토리

Delayed Upgrade Clock